On the 16th of Sep, high officials from MSD visited our center. The delegation include MSD SVP Franchise Head Oncology Dr. D. Gary Gilliland; MSD SVP Emerging Markets  Dr. Ruiping Dong; MSD VP Asia Pacific Regional R&D Dr. Mingqiang Zhang; MSD Clinical Research Director Dr. Zaiqi Wang; MSD Clinical Research Manager Dr. Karen Zhou.

After discussion with the leaders from our center. They visited the newly opened Fudan Start Phase One Clinical Trial Center. Director of Internatiaonl Affaire Dr. Xi Cheng introduced our center, CEO of Start Shanghai, Ms. Carol Zhu did the introduction of the center and lead the visit.